Therapeutic Drug Monitoring Market Share

Statistics for the 2023 & 2024 Therapeutic Drug Monitoring market share, created by Mordor Intelligence™ Industry Reports. Therapeutic Drug Monitoring share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Therapeutic Drug Monitoring Industry

The therapeutic drug monitoring market is moderately competitive and consists of several major players. Some companies are expanding their market position by adopting various strategies, such as acquisitions and mergers, while others are developing new techniques for treating multiple disease indications and introducing new products to maintain their market share. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Danaher Corporation (Beckman Coulter Inc.), and Siemens Healthcare GmbH, among others.

Therapeutic Drug Monitoring Market Leaders

  1. Thermo Fisher Scientific

  2. Bio-Rad Laboratories

  3. F. Hoffmann-La Roche Ltd

  4. Danaher Corporation (Beckman Coulter, Inc.)

  5. Siemens Healthcare GmbH

*Disclaimer: Major Players sorted in no particular order

Picture3.png

Therapeutic Drug Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)